SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16723784
Source:
http://linkedlifedata.com/resource/pubmed/id/16723784
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001554
,
umls-concept:C0005116
,
umls-concept:C0155709
,
umls-concept:C0879626
,
umls-concept:C1261322
,
umls-concept:C1516634
pubmed:issue
6
pubmed:dateCreated
2006-5-25
pubmed:abstractText
Bepridil hydrochloride (Bpd) has attracted attention as an effective drug for atrial fibrillation (AF) and atrial flutter (AFL). However, serious adverse effects, including torsade de pointes (Tdp), have been reported.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101137683
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Bepridil
,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1346-9843
pubmed:author
pubmed-author:DaidaHiroyukiH
,
pubmed-author:KawanoYasunobuY
,
pubmed-author:NakazatoKaoruK
,
pubmed-author:NakazatoYujiY
,
pubmed-author:SasakiAkitoshiA
,
pubmed-author:TokanoTakashiT
,
pubmed-author:YasudaMasayukiM
pubmed:issnType
Print
pubmed:volume
70
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
662-6
pubmed:meshHeading
pubmed-meshheading:16723784-Age Factors
,
pubmed-meshheading:16723784-Aged
,
pubmed-meshheading:16723784-Anti-Arrhythmia Agents
,
pubmed-meshheading:16723784-Atrial Fibrillation
,
pubmed-meshheading:16723784-Atrial Flutter
,
pubmed-meshheading:16723784-Bepridil
,
pubmed-meshheading:16723784-Bradycardia
,
pubmed-meshheading:16723784-Dizziness
,
pubmed-meshheading:16723784-Follow-Up Studies
,
pubmed-meshheading:16723784-Humans
,
pubmed-meshheading:16723784-Long QT Syndrome
,
pubmed-meshheading:16723784-Male
,
pubmed-meshheading:16723784-Middle Aged
,
pubmed-meshheading:16723784-Monitoring, Physiologic
,
pubmed-meshheading:16723784-Potassium
,
pubmed-meshheading:16723784-Torsades de Pointes
pubmed:year
2006
pubmed:articleTitle
Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter.
pubmed:affiliation
Division of Cardiology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. ysd@med.juntendo.ac.jp
pubmed:publicationType
Journal Article
,
Clinical Trial